Allworth Financial’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.26K Buy
65
+18
+38% +$1.8K ﹤0.01% 3818
2025
Q4
$4.57K Buy
47
+11
+31% +$944 ﹤0.01% 3766
2025
Q3
$2.56K Buy
36
+35
+3,500% +$2.33K ﹤0.01% 3890
2025
Q2
$60 Buy
+1
New +$55 ﹤0.01% 4436
2022
Q1
Sell
-184
Closed -$9K 2241
2021
Q4
$9K Buy
+184
New +$7.42K ﹤0.01% 1404

Other funds holding IRMD

Allworth Financial's IRMD Position: Q1 2026 in Review

Allworth Financial increased its iRadimed (IRMD) stake by 38% in Q1 2026, buying an estimated $1.8K and bringing the position to 65 shares worth $6.26K. The position accounts for ﹤0.01% of the portfolio, ranked #3818.

Allworth Financial first reported a position in IRMD in Q4 2021 and has held it in 5 quarters since. The position peaked at $9K in Q4 2021. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Allworth Financial held 65 shares of iRadimed worth $6.26K as of Q1 2026.
  • Allworth Financial bought 18 iRadimed shares in Q1 2026, an estimated $1.8K.
  • iRadimed made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #3818 holding.
  • Allworth Financial first reported a position in iRadimed in Q4 2021 and has held it in 5 quarters since.
  • Allworth Financial's iRadimed position peaked at $9K in Q4 2021.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.